Vaccination

FDA gives nod to RSV vaccine for people in their 50s

The U.S. Food and Drug Administration on Friday has for the first time approved the use of a respiratory syncytial virus (RSV) vaccine for people in their 50s who are at increased risk for the illness.

Health

Locums and permanent GPs equally safe, study says

There is no evidence that locum doctors are less clinically competent or practice less safely than permanent doctors, a study in England led by University of Manchester researchers has shown.

page 1 from 40